Clinical Trials
2 trialsNCT04445844 2025-04-04
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study
Rutgers, The State University of New Jersey
Phase 2 Active not recruiting
NCT03723915 2022-10-05
Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer
Northwestern University
Phase 2 Terminated